Revolution Medicines (RVMD) Return on Equity [ROE] (2020 - 2026)
Revolution Medicines (RVMD) recorded Return on Equity [ROE] of -86.13% in Q2 2026, down 44.95 percentage points from -41.18% a year earlier but up 1.49 percentage points from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Revolution Medicines reported Return on Equity [ROE] of -58.07%, down 28.74 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of +9.09 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -29.33% in FY2024 (+5.42 pp), -34.75% in FY2023 (+3.87 pp), -38.63% in FY2022 (-3.89 pp) and -34.74% in FY2021 (+32.42 pp).
- Quarterly Return on Equity [ROE] has ranged from -87.61% in Q1 2026 to -25.49% in Q3 2021 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has declined for six consecutive quarters, with an average year-over-year change of -21.35 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 11.30 percentage points in Q2 2023, against a drop of 55.50 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -87.61% (Q1 2026), -70.09% (Q4 2025) and -55.51% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | - |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 4.97% |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | -86.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -86.13% |
| Mar 31, 2026 | -87.61% |
| Dec 31, 2025 | -70.09% |
| Sep 30, 2025 | -55.51% |
| Jun 30, 2025 | -41.18% |
| Mar 31, 2025 | -32.12% |
| Dec 31, 2024 | -31.32% |
| Sep 30, 2024 | -35.61% |
| Jun 30, 2024 | -31.05% |
| Mar 31, 2024 | -27.27% |
| Dec 31, 2023 | -32.76% |
| Sep 30, 2023 | -37.48% |
| Jun 30, 2023 | -31.46% |
| Mar 31, 2023 | -31.65% |
| Dec 31, 2022 | -36.40% |
| Sep 30, 2022 | -41.49% |
| Jun 30, 2022 | -42.77% |
| Mar 31, 2022 | -35.99% |
| Dec 31, 2021 | -30.16% |
| Sep 30, 2021 | -25.49% |
API Access
Revolution Medicines Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();